Rapt Therapeutics Inc
(RAPT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Sales | 756 | 966 | 869 | 1,222 | 1,302 |
| Gross Profit | 756 | 966 | 869 | 1,222 | 1,302 |
| Operating Expenses | 18,790 | 19,499 | 16,950 | 17,783 | 14,387 |
| Operating Income | -18,034 | -18,533 | -16,081 | -16,561 | -13,085 |
| Other Income | 105 | -118 | -29 | 47 | 549 |
| Pre-tax Income | -17,929 | -18,651 | -16,110 | -16,514 | -12,536 |
| Income Tax | N/A | N/A | N/A | N/A | 199 |
| Net Income Continuous | -17,929 | -18,651 | -16,110 | -16,514 | -12,735 |
| Net Income | $-17,929 | $-18,651 | $-16,110 | $-16,514 | $-12,735 |
| EPS Basic Total Ops | -4.88 | -5.04 | -5.04 | -5.28 | -4.16 |
| EPS Basic Continuous Ops | -4.80 | -5.06 | -5.04 | -5.32 | -4.16 |
| EPS Diluted Total Ops | -4.88 | -5.04 | -5.04 | -5.28 | -4.16 |
| EPS Diluted Continuous Ops | -4.80 | -5.06 | -5.04 | -5.32 | -4.16 |
| EBITDA(a) | $-17,373 | $-17,894 | $-15,613 | $-16,063 | $-12,591 |